investorrelations.medtronic.comInvestor Overview | Medtronic

Skip to main navigation Citizenship Investors Newsroom Careers About Patients Healthcare Professionals About Patients Healthcare Professionals Citizenship Investors Newsroom Careers X Creating Long-term Shareholder Value Our leading technologies and services create value on a global scale. Learn More -- Investor Overview Latest Investor Information Feb 18, 2020 8:00 AM EST Q3 2020 Medtronic plc Earnings Conference Call Jan 24, 2020 8:30 AM PST Medtronic Investor Briefing at NANS Jan 13, 2020 9:30 AM PST 38th Annual J.P. Morgan Healthcare Conference - Q&A Session Jan 13, 2020 9:00 AM PST 38th Annual J.P. Morgan Healthcare Conference Latest Press Releases Jan 30, 2020 Medtronic Receives CE Mark for Cobalt™ and Crome™ Portfolio of BlueSync™-Enabled Implantable Defibrillators, Cardiac Resynchronization Therapy-Defibrillators Jan 23, 2020 Medtronic Receives FDA Approval for Trial Evaluating New Energy Source with Pulsed Electric Fields to Treat Atrial Fibrillation Jan 23, 2020 Medtronic Launches Efficio™ Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II Jan 21, 2020 DTM™ Spinal Cord Stimulation Using the Medtronic Intellis™ Platform Shows Superior Back Pain Relief Compared to Conventional SCS Therapy in an RCT Read More 2019 Medtronic ESG & Corporate Citizenship Highlights LEARN MORE Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption Important Information on the Irish Dividend Withholding Tax. LEARN MORE QUARTERLY RESULTS Medtronic Q2 revenue results and financial tables. LEARN MORE INVESTOR FUNDAMENTALS View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios. LEARN MORE INSTITUTIONAL INVESTOR AND ANALYST MEETING 2018 Promising therapy and product innovation detailed by company leaders READ HIGHLIGHTS ACCESS WEBCAST REPLAY Sustainability Index Endorsements Read more about our Sustainability efforts. READ MORE Medtronic Spotlight Jim Cramer of CNBC’s “Mad Money” interviews Omar Ishrak, Medtronic Chairman & CEO from the JP Morgan Healthcare Conference about product development and his legacy Play Video History of Medtronic A video history of the company. Play Video Investor Contacts Stock Transfer Agent EQ Shareowner Services +1 888-648-8154 Medtronic Investor Relations Department investor.relations@medtronic.com +1 763-505-2692 Ryan Weispfenning Vice President, Investor Relations Btn --- > View All (Home Page) View All Tools Investor Events SEC Filings Investor Alerts Investor Contacts Medtronic plc Copyright West LLC. Minimum 15 minutes delayed. Investor Resources Dividend Information Dividend Tax Treatment – IRS 8937 Dividend Withholding Tax Information Dividend History Dividend Reinvestment Payment History - DRIP Events & Presentations Past Events & Presentations General Manager Call Series Financial Information Overview SEC Filings Annual Meeting & Reports Quarterly Results Debt Agency Ratings Fundamentals Analyst Coverage Analyst Estimates Sustainability Reports Stock Information Stock Performance Stock Chart Historic Stock Lookup Investment Calculator Cost Basis Calculator Medtronic Historical Share Data News News Shareholder Services Annual Meeting Direct Stock Purchase Electronic Delivery of Proxy Materials Stock Transfer Agent & Registrar Investor FAQs Contact Us Medtronic - Covidien Transaction Transaction Tax Impacts FAQ Transaction Documents Capital Acquisitions Tax (CAT) Covidien Historical Investor Archive Company Information Mission History Corporate Governance Corporate Responisbility Locations Learn how Medtronic is innovating for healthcare. X X Terms of Use Privacy Statement Covidien Products Contact © 2020 Medtronic...